Radiotherapy and chemotherapy have been considered ineffective for renal cell carcinoma treatment, but the introduction of TKI and mTOR targeted therapies and immunotherapies in combinations has increased the response rate of patients [3]. Here, MTOR is linked to hereditary clear cell renal cell carcinoma.